Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 507-520

  Kumar Singh, Samir ^a,c   Cras, Patrick ^b   Wang, Rong ^d   Kros, John M ^e   Van Swieten, Johan ^f   Lübke, Ursula ^b   Ceuterick, Chantal ^b   Serneels, Sally ^a   Vennekens, Krist'l ^a   Timmermans, Jean Pierre ^c   Van Marck, Eric ^c   Martin, Jean Jacques ^b   Van Duijn, Cornelia M ^b,e   Van Broeckhoven, Christine ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONFOCAL MICROSCOPY; ELECTRON MICROSCOPY; FAMILIAL DISEASE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MASS SPECTROMETRY; NETHERLANDS; NEURITE; ONSET AGE; PRIORITY JOURNAL; SENILE PLAQUE; STROKE; THREE DIMENSIONAL IMAGING; TISSUE SECTION;

EID: 0036968368     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64207-1     Document Type: Article

References (79)

1. Selkoe DJ: The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 1998, 8:447-453
2. Wisniewski HM, Bancher C, Barcikowska M, Wen GY, Currie J: Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol (Berl) 1989, 78:337-347
3. Hardy J: Amyloid, the presenilins and Alzheimer disease. TINS 1997, 20:154-159
4. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1992, 1:345-347
5. Mann DM, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, Lannfelt L, Winblad B, Maat-Schieman ML, Rossor MN: Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996, 148: 1257-1266
6. Pike CJ, Overman MJ, Cotman CW: Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. J Biol Chem 1995, 270:23895-23898
7. Tekirian TL, Yang AY, Glabe C, Geddes JW: Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta 1-40 and -42. J Neurochem 1999, 73:1584-1589
8. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 1994, 13:45-53
9. Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, Ball MJ: Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 1994, 269:10987-10990
10. Lamer AJ: Hypothesis: amyloid beta-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease. Neurobiol Aging 1999, 20:65-69
11. Jarrett JT, Lansbury Jr PT: Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993, 73:1055-1058
12. Dickson DW: The pathogenesis of senile plaques J Neuropathol Exp Neurol 1997, 56:321-339
13. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, George-Hyslop P, Westaway D: A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000, 408:979-982
14. Glenner GG, Henry JH, Fujihara S: Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981, 1:120-129
15. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y: Amyloid beta protein (Aβ) deposition: aβ42(43) precedes Aβ40 in Down syndrome [see comments]. Ann Neurol 1995, 37:294-299
16. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GT, Luyendijk W, Frangione B: Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248:1124-1126
17. Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, Vegter-Van dV, Roos RA: Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990, 248:1120-1122
18. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin J-J, Hofman A, Van Broeckhoven C: Presenile dementia and cerebral haemorrhage linked to a mutation at condon 692 of the β-amyloid precursor protein gene. Nat Genet 1992, 1:218-221
19. Bugiani O, Padovani A, Magoni M, Andora G, Sgarzi M, Savoiardo M, Bizzi A, Giaccone G, Rossi G, Tagliavini F: An Italian type of HCHWA-D. Neurobiol Aging 1998. 19:S238 (Abstract)
20. Nilsberth C, Westlind-Danielsson A, Eckman C, Condron MM, Axelman K, Forsell C, Stenh C, Luthman H, Teplow DB, Younkin SG, Naslund J, Lannfelt L: The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 2001, 4:887-893
21. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001, 49:697-705
22. Haan J, Roos RAC, Briet PE, Herpers MJHM, Luyendijk W, Bots GTAM: Hereditary cerebral haemorrhage with amyloidosis of the Dutch type Clin Neurol Neurosurg 1989, 81:285-290
23. Timmers WF, Tagliavini F, Haan J, Frangione B: Parenchymal preamyloid and amyloid deposits in the brain of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurosci Lett 1990, 118:223-226
24. Mann DM, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, Lannfelt L, Winblad B, Maat-Schieman ML, Rossor MN: Use 2040-predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996, 148:1257-1266
25. Maat-Schieman ML, Yamaguchi H, van Duinen SG, Natte R, Roos RA: Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis. Acta Neuropathol (Berl) 2000, 99:409-419
26. Cras P, van Harskamp F, Hendriks L, Ceuterick C, van Duijn CM, Stefanko SZ, Hofman A, Kros JM, Van Broeckhoven C, Martin JJ: Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation. Acta Neuropathol 1998, 96:253-260
27. Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG: Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001, 50:765-772
28. Howland DS, Savage MJ, Huntress FA, Wallace RE, Schwartz DA, Loh T, Melloni RHJ, DeGennaro LJ, Greenberg BD, Siman R: Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging 1995, 16:685-699
29. Kumar-Singh S, Dewachter I, Moechars D, Lubke U, De Jonghe C, Ceuterick C, Checler F, Naidu A, Cordell B, Cras P, Van Broeckhoven C, Van Leuven F: Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 2000, 7:9-22
30. Watson DJ, Selkoe DJ, Teplow DB: Effects of the amyloid precursor protein Glu693→Gln 'Dutch' mutation on the production and stability of amyloid beta-protein. Biochem J 1999, 340:703-709
31. Fraser PE, Nguyen JT, Inouye H, Surewicz WK, Selkoe DJ, Podlisny MB, Kirschner DA: Fibril formation by primate, rodent and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochemistry 1992, 31:10716-10723
32. Clements A, Allsop D, Walsh DM, Williams CH: Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease. J Neurochem 1996, 179:1247-1254
33. Wisniewski T, Ghiso J, Frangione B: Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation Biochem Biophys Res Commun 1991, 180:1528
34. Davis-Salinas J, Van Nostrand WE: Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells J Biol Chem 1995, 270:20887-20890
35. Van Nostrand WE, Davis-Salinas J, Saporito-Irwin SM: Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann NY Acad Sci 1996, 777:297-302
36. Miravalle L, Tokuda T, Chiarle R, Giaccone G, Bugiani O, Tagliavini F, Frangione B, Ghiso J: Substitutions at codon 22 of Alzheimer's A {beta} peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000, 275: 27110-27116
37. Wang Z, Natte R, Berliner JA, van Duinen SG, Vinters HV: Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. Stroke 2000, 31:534-538
38. Haass C, Hung AY, Selkoe DJ, Teplow DB: Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor J Biol Chem 1994, 269:17741-17748
39. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H: BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci USA 2000, 97:9712-9717
40. Clements A, Walsh DM, Williams CH, Allsop D: Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide. Neurosci Lett 1993, 161:17-20
41. Walsh DM, Hartley DM, Condron MM, Selkoe DJ, Teplow DB: In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer's disease. Biochem J 2001, 355:869-877
42. Roks G, van Harskamp F, De K, I, Cruts M, De Jonghe C, Kumar-Singh S, Tibben A, Tanghe H, Niermeijer MF, Hofman A, van Swieten JC, Van Broeckhoven C, van Duijn CM: Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 2000, 123:2130-2140
43. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985, 42:1097-1105
44. Arai T, Akiyama H, Ikeda K, Kondo H, Mori H: Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease. Brain Res 1999, 823:202-206
45. Kumar-Singh S, Vermeulen PB, Weyler J, Segers K, Weyn B, Van Daele A, Van Oosterom AT, Dirix LY. Van Marck E: Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol 1997, 182:211-216
46. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ: Beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:10836-10840
47. Wang R, Sweeney D, Gandy SE, Sisodia SS: The profile of soluble amyloid β protein in cultured cell media. Detection and quantification of amyloid β protein and variants by immunoprecipitation-mass spectrometry. J Biol Chem 1996, 271:31894-31902
48. Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, Lofgren A, Vanderhoeven I, Backhovens H, Vanmechelen E, Kroisel PM, Van Broeckhoven C: Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated abeta(42) in Alzheimer's disease. Hum Mol Genet 2000, 9:2589-2598
49. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259
50. Vinters HV, Natte R, Maat-Schieman ML, van Duinen SG, Hegeman-Kleinn I, Welling-Graafland C, Haan J, Roos RA: Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol (Berl) 1998, 95:235-244
51. Tagliavini F, Giaccone G, Bugiani O, Frangione B: Ubiquitinated neurites are associated with preamyloid and cerebral amyloid beta deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type. Acta Neuropathol (Berl) 1993, 85:267-271
52. Russo C, Schettini G, Saido TC, Hulette C, Lippa C, Lannfelt L, Ghetti B, Gambetti P, Tabaton M, Teller JK: Presenilin-1 mutations in Alzheimer's disease. Nature 2000, 405:531-532
53. Divry P.: La patochimie generale et cellulaire des processus seniles et preseniles Proceedings of the First International Congress of Neuropathology Rome, Rosenberg & Sellier, 1952, pp 313-345
54. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L, Eckman C, Golde TE, Younkin SG: An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 1994, 264:1336-1340
55. De Jonghe C, Zehr C, Yager D, Prada CM, Younkin S, Hendriks L, Van Broeckhoven C, Eckman CB: Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion Neurobiol Dis 1998, 5:281-286
56. Scholtz W: Studien zur pathologie der hirngefässe. II Die drüsige Entartung der hirnarterien und capillären. Z Neurol 1938, 162:694-715
57. Ishii T: Enzyme histochemical studies of senile plaques and the plaque-like degeneration of arteries and capillaries (Scholz). Acta Neuropatho) (Berl) 1969, 14:250-260
58. Mandybur TI: The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975, 25:120-126
59. Glenner GG: Amyloid deposits and amyloidosis The beta-fibrilloses (first of two parts) N Engl J Med 1980, 302:1283-1292
60. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y: The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia Morphological mechanism of senile plaque production. Virchows Arch B Cell Pathol Incl Mol Pathol 1982, 40: 121-129
61. Arai H, Sagi N, Noguchi I, Haga S, Ishii T, Makino Y, Kosaka K: An immunohistochemical study of beta-protein in Alzheimer-type dementia brains. J Neurol 1989, 236:214-217
62. Iwamoto N, Nishiyama E, Ohwada J, Arai H: Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: relationship to blood vessels. Acta Neuropathol (Berl) 1997, 93:334-340
63. Miyakawa T, Kimura T, Hirata S, Fujise N, Ono T, Ishizuka K, Nakabayashi J: Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease. Ann NY Acad Sci 2000, 903: 46-54
64. Kawai M, Kalaria RN, Harik SI, Perry G: The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 1990, 137:1435-1446
65. Akiyama H, Yamada T, McGeer PL, Kawamata T, Tooyama I, Ishii T: Columnar arrangement of beta-amyloid protein deposits in the cerebral cortex of patients with Alzheimer's disease. Acta Neuropathol (Berl) 1993, 85:400-403
66. Lippa CF, Hamos JE, Smith TW, Pulaski-Salo D, Drachman DA: Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques or tangles. Arch Neurol 1993, 50:1088-1092
67. Uchihara T, Kondo H, Akiyama H, Ikeda K: White matter amyloid in Alzheimer's disease brain. Acta Neuropathol (Berl) 1995, 90:51-56
68. Yamaguchi H, Sugihara S, Ogawa A, Saido TC, Ihara Y: Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques Acta Neuropathol (Berl) 1998, 95:217-222
69. Kimchi EY, Kajdasz S, Bacskai BJ, Hyman BT: Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy. J Neuropathol Exp Neurol 2001, 60:274-279
70. Esler WP, Stimson ER, Ghilardi JR, Lu YA, Felix AM, Vinters HV, Mantyh PW, Lee JP, Maggio JE: Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry 1996, 35:13914-13921
71. Wisniewski HM, Wegiel J, Wang KC, Lach B: Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol (Berl) 1992, 84:117-127
72. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE: Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998, 153:725-733
73. Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M: Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999, 96:14088-14093
74. Vidal R. Calero M, Piccardo P, Farlow MR, Unverzagt FW, Mendez E, Jimenez-Huete A, Beavis R, Gallo G, Gomez-Tortosa E, Ghiso J, Hyman BT, Frangione B, Ghetti B: Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. Acta Neuropathol (Berl) 2000, 100:1-12
75. Mann DM, Pickering-Brown SM, Takeuchi A, Iwatsubo T: Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. Am J Pathol 2001, 158:2165-2175
76. Dermaut B, Kumar-Singh S, De Jonghe C, Cruts M, Lofgren A, Lubke U, Cras P, Dom R, De Deyn PP, Martin JJ, Van Broeckhoven C: Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 2001, 124:2383-2392
77. Smith MJ, Kwok JB, McLean CA, Kril JJ, Broe GA, Nicholson GA, Cappai R, Hallupp M, Cotton RG, Masters CL, Schofield PR, Brooks WS: Variable phenotype of Alzheimer's disease with spastic paraparesis Ann Neurol 2001, 49:125-129
78. de la Torre JC: Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathol (Berl) 1999, 98:1-8
79. Haan J, Van Broeckhoven C, van Duijn CM, Voorhoeve E, van Harskamp F, van Swieten JC, Maat-Schieman MLC, Roos RAC, Bakker E: The apolipoprotein E [epsilon]4 allele does not influence the clinical expression of the amyloid precursor protein-gene codon 693 or 692 mutations. Ann Neurol 1994, 36:434-437